These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18572881)

  • 1. Chemical and biological profiles of novel copper(II) complexes containing S-donor ligands for the treatment of cancer.
    Giovagnini L; Sitran S; Montopoli M; Caparrotta L; Corsini M; Rosani C; Zanello P; Dou QP; Fregona D
    Inorg Chem; 2008 Jul; 47(14):6336-43. PubMed ID: 18572881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
    Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity.
    Giovagnini L; Sitran S; Castagliuolo I; Brun P; Corsini M; Zanello P; Zoleo A; Maniero A; Biondi B; Fregona D
    Dalton Trans; 2008 Dec; (47):6699-708. PubMed ID: 19153618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc(II) complexes with dithiocarbamato derivatives: structural characterisation and biological assays on cancerous cell lines.
    Nagy EM; Sitran S; Montopoli M; Favaro M; Marchiò L; Caparrotta L; Fregona D
    J Inorg Biochem; 2012 Dec; 117():131-9. PubMed ID: 23085593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
    Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
    J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effect, differentiation, inhibition of growth and theoretical calculations of an N,N-donor ligands and its platinum(II), palladium(II) and copper(II) complexes.
    Miernicka M; Szulawska A; Czyz M; Lorenz IP; Mayer P; Karwowski B; Budzisz E
    J Inorg Biochem; 2008 Feb; 102(2):157-65. PubMed ID: 17868889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
    Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
    Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
    Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
    J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of cis-platinum(II) cycloaliphatic amidine complexes: Ring size and solvent effects on the biological activity.
    Marzano C; Sbovata SM; Gandin V; Michelin RA; Venzo A; Bertani R; Seraglia R
    J Inorg Biochem; 2009 Aug; 103(8):1113-9. PubMed ID: 19560209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic coordination chemistry and cytotoxicity of copper(II) complexes with methyl substituted 4-nitropyridine N-oxides.
    Puszko A; Brzuszkiewicz A; Jezierska J; Adach A; Wietrzyk J; Filip B; Pełczynska M; Cieslak-Golonka M
    J Inorg Biochem; 2011 Aug; 105(8):1109-14. PubMed ID: 21726775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, crystal structure and biological activities of copper(II) complexes with chelating bidentate 2-substituted benzimidazole ligands.
    Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Grünert R; Gdaniec M; Tabin P
    J Inorg Biochem; 2006 Aug; 100(8):1389-98. PubMed ID: 16740312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic and cytotoxic studies of the novel designed palladium(II) complexes: beta-lactoglobulin and K562 as the targets.
    Divsalar A; Saboury AA; Yousefi R; Moosavi-Movahedi AA; Mansoori-Torshizi H
    Int J Biol Macromol; 2007 Mar; 40(4):381-6. PubMed ID: 17097727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles.
    Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Gdaniec M
    Arch Pharm (Weinheim); 2007 Jul; 340(7):333-8. PubMed ID: 17611942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New copper(I) phosphane complexes of dihydridobis(3-nitro-1,2,4-triazolyl)borate ligand showing cytotoxic activity.
    Marzano C; Pellei M; Alidori S; Brossa A; Lobbia GG; Tisato F; Santini C
    J Inorg Biochem; 2006 Feb; 100(2):299-304. PubMed ID: 16387362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure and biological activity of copper(II) complexes of 4-(2-pyridylmethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione and 4-(2-pyridylethyl)-1,7-dimethyl-1,4,7-triazonane-2,6-dione.
    Singh AP; Kaushik NK; Verma AK; Hundal G; Gupta R
    Eur J Med Chem; 2009 Apr; 44(4):1607-14. PubMed ID: 18775587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumoral activity of non-platinum xanthate complexes.
    Friebolin W; Schilling G; Zöller M; Amtmann E
    J Med Chem; 2005 Dec; 48(25):7925-31. PubMed ID: 16335917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising anticancer mono- and dinuclear ruthenium(III) dithiocarbamato complexes: systematic solution studies.
    Nagy EM; Nardon C; Giovagnini L; Marchiò L; Trevisan A; Fregona D
    Dalton Trans; 2011 Nov; 40(44):11885-95. PubMed ID: 21971872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro biological activity of new platinum(II) and palladium(II) complex compounds].
    Malinowska K; Modranka R; Kubiak K; Mrowicka M; Kedziora J; Klimczak A; Rutkowski M
    Pol Merkur Lekarski; 2009 Jan; 26(151):52-6. PubMed ID: 19391508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes.
    Tan C; Liu J; Chen L; Shi S; Ji L
    J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.